46 results on '"Yankelevitz D"'
Search Results
2. Coronary Artery Calcium Scans Powered By Artificial Intelligence (AI-CAC) Predicts Atrial Fibrillation And Stroke Comparably To Cardiac Magnetic Resonance Imaging: The Multi-ethnic Study Of Atherosclerosis (MESA).
3. Automated Left Ventricular Volumetry Using Artificial Intelligence In Coronary Calcium Scans (AI-CAC) Predicts Heart Failure Comparably To Cardiac MRI And Outperforms NT-proBNP: The Multi-ethnic Study Of Atherosclerosis (MESA).
4. AI-enabled Cardiac Chambers Volumetry In Coronary Calcium Scans (AI-CAC) Predicts Heart Failure And Outperforms NT-proBNP: The Multi-Ethnic Study Of Atherosclerosis.
5. EP.07G.03 Radiologic Predictors of Angiolymphatic Invasion in Patients with Non-Small Cell Lung Cancer (3.0mm-30.0mm).
6. EP.05B.04 Correlation Between Radiologic Feature and Spread Through Air Space in Lung Solid Adenocarcinoma 30.0 mm or Less in Maximum Diameter.
7. P2.04B.08 Terminology in Lung Cancer Screening and Early Detection - IASLC Early Detection and Screening Committee Recommendations.
8. P2.04B.09 A Qualitative Evaluation of the Critical Role of Lung Cancer Screening Program Navigators.
9. Incidence and cytological features of pulmonary hamartomas indeterminate on CT scan
10. Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer
11. AI-enabled Left Atrial Volumetry In Coronary Calcium Scans (AI-CAC) Predicts Atrial Fibrillation As Early As One Year, Improves Charge-AF, And Outperforms NT-proBNP: The Multi-ethnic Study Of Atherosclerosis.
12. EP04.05-06 Centralized Shared Decision Making in Lung Cancer Screening: Unexpected Consequences.
13. EP04.05-04 Impact of Magnitude of Lung Cancer Screening Benefit on Uptake.
14. P1.26-05 Sublobar Resection is Equivalent to Lobectomy for Stage IA Adenocarcinoma Presenting as Subsolid Nodule.
15. AI-enabled Automated Cardiac Chambers Volumetry In Non-contrast ECG-gated Cardiac Scans Vs. Non-contrast Non-gated Lung Scans.
16. EP07.01-27 The Impact of Comorbidities on Exercise Level after Treatment for Early-Stage Lung Cancer Patients.
17. P1.17-01 Lung Cancer Screening in Low- and Middle-income Countries - Report on Status, Challenges and Perspectives from WCLC2022 and LALCA2023.
18. EP02.03-011 Timeliness of Surgery for Early-Stage Lung Cancer: Perspectives from Surgeons and Patients.
19. EP01.04-005 Quantitative Characteristics in Global CT Lung Cancer Screening Populations Using the ELIC Distributed Database and Computation Environment.
20. P2.12-05 Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes with PD-L1 Blockade to Reverse Type-2Mediated Immunosuppression.
21. P1.02-02 Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries.
22. AI-enabled Cardiac Chambers Volumetry In Non-contrast Coronary Artery Calcium CT Scans Vs. Contrast-enhanced Coronary CT Angiography Scans In The Same Patients.
23. Opportunistic AI-enabled Automated Bone Mineral Density Measurements In Lung Cancer Screening And Coronary Calcium Scoring CT Scans Are Equivalent.
24. P62.07 Pre-surgical Assessment of Mediastinal Lymph Node Metastases in Stage IA Non-small-cell Lung Cancers.
25. A public image database to support research in computer aided diagnosis.
26. EP01.05-011 Radiologic Features of Nodules Attached to the Mediastinal or Diaphragmatic Pleura.
27. MA11.07 The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World.
28. Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of "truth".
29. Commentary: developing CT image-processing tools to accelerate progress in lung cancer drug development.
30. Stage of lung cancer in relation to its size: part 2. Evidence.
31. Stage of lung cancer in relation to its size: part 1. Insights.
32. Early lung cancer action project: initial findings on repeat screenings.
33. Screening for lung cancer.
34. FP13.02 Costal Pleura-attached Noncalcified Nodules Newly Seen on Annual Low-Dose CT Screenings.
35. MA10.03 Balance Between Decreased False Positives and Delayed Diagnosis in Lung Cancer Screening.
36. OA01.01 Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls.
37. Needle-tip repositioning during computed-tomography-guided transthoracic needle aspiration biopsy of small deep pulmonary lesions: minor adjustments make a big difference.
38. Variability in lesion depth on prone and supine CT scans of the chest: implications for the accuracy of transthoracic needle aspiration biopsy.
39. Appropriate window and level settings in CT-guided biopsies.
40. EP1.04-15 NSCLC Response Determinants to Chemoimmunotherapy: Deep Profiling of Tumors Following Neoadjuvant Cemiplimab and Chemotherapy.
41. P2.11-08 CT Screening of Never Smokers.
42. ES01.02 Image Interpretation and Advances from the Perspective of the Radiologist.
43. Needle-tip localization for CT-guided biopsies.
44. P2.11-33 Organizational Readiness for Implementation of Lung Cancer Screening in a Veterans Affairs Healthcare System.
45. P2.11-23 Performance of Lung Cancer Risk Prediction Models in I-ELCAP Smokers.
46. S01.04 Lung Cancer Screening: 1999 to Date – What Have We Learnt?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.